| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is a naturally occurring naphthoquinone derivative. –Plumbagin can undergo redox cycling to generate reactive oxygen species (ROS) -apototosis, activation of caspases, modulation of Bax, Bcl‑2, loss of MMP. -Cell cycle arrest in cancer cells, often at the G0/G1, or G2/M phases. -May inhibit NF‑κB activation – MAPK Pathways – PI3K/Akt Pathway -Downregulation of (VEGF) and matrix metalloproteinases (MMPs). -Seems capable of raising ROS in normal and cancer cells (#2004) -ic50 cancer cells 1-10uM, normal cells >10uM
|
| Source: |
| Type: Proapototic protein |
| BAX is a member of the Bcl-2 gene family. Pro-apoptotic protein that forms heterodimers with anti-apoptotic BCL2 proteins; involved in various cellular activities and regulated by p53; mediates the release of cytochrome c from mitochondria. |
| 2005- | PLB, | Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2) |
| - | in-vivo, | Nor, | EL4 | - | in-vitro, | AML, | Jurkat |
| 5161- | PLB, | Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells |
| - | in-vitro, | SCC, | SCC25 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:299 Target#:26 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid